JP2000511771A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2000511771A5 JP2000511771A5 JP1997537532A JP53753297A JP2000511771A5 JP 2000511771 A5 JP2000511771 A5 JP 2000511771A5 JP 1997537532 A JP1997537532 A JP 1997537532A JP 53753297 A JP53753297 A JP 53753297A JP 2000511771 A5 JP2000511771 A5 JP 2000511771A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Description
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1599996P | 1996-04-23 | 1996-04-23 | |
| US60/015,999 | 1996-04-23 | ||
| PCT/CA1997/000265 WO1997040063A2 (en) | 1996-04-23 | 1997-04-23 | Pathogenic escherichia coli associated protein espa |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008233530A Division JP5058106B2 (ja) | 1996-04-23 | 2008-09-11 | 病原性大腸菌関連タンパク質 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2000511771A JP2000511771A (ja) | 2000-09-12 |
| JP2000511771A5 true JP2000511771A5 (ja) | 2004-12-09 |
Family
ID=21774805
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP09537532A Ceased JP2000511771A (ja) | 1996-04-23 | 1997-04-23 | 病原性大腸菌関連タンパク質 |
| JP2008233530A Expired - Fee Related JP5058106B2 (ja) | 1996-04-23 | 2008-09-11 | 病原性大腸菌関連タンパク質 |
| JP2010043983A Pending JP2010132698A (ja) | 1996-04-23 | 2010-03-01 | 病原性大腸菌関連タンパク質 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008233530A Expired - Fee Related JP5058106B2 (ja) | 1996-04-23 | 2008-09-11 | 病原性大腸菌関連タンパク質 |
| JP2010043983A Pending JP2010132698A (ja) | 1996-04-23 | 2010-03-01 | 病原性大腸菌関連タンパク質 |
Country Status (10)
| Country | Link |
|---|---|
| US (4) | US6355254B1 (ja) |
| EP (1) | EP0904288B1 (ja) |
| JP (3) | JP2000511771A (ja) |
| KR (1) | KR20000010667A (ja) |
| AU (1) | AU2562897A (ja) |
| BR (1) | BR9710433A (ja) |
| CA (1) | CA2252372C (ja) |
| DK (1) | DK0904288T3 (ja) |
| ES (1) | ES2389625T3 (ja) |
| WO (1) | WO1997040063A2 (ja) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2252438C (en) * | 1996-04-19 | 2011-03-29 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability |
| ES2389625T3 (es) * | 1996-04-23 | 2012-10-29 | The University Of British Columbia | Vacuna que comprende la proteína EspA asociada a Escherichia coli patógena |
| US6204004B1 (en) | 1997-03-21 | 2001-03-20 | University Of Maryland, Baltimore | Immunodiagnostic test for enterohemorrhagic Escherichia coli infection |
| US7208574B1 (en) | 1997-11-12 | 2007-04-24 | The University Of British Columbia | Host receptor for pathogenic bacteria |
| WO1999045136A1 (en) * | 1998-03-05 | 1999-09-10 | University Of British Columbia | Methods for assaying type iii secretion inhibitors |
| WO1999055364A2 (en) * | 1998-04-24 | 1999-11-04 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Proteins that direct the secretion of virulence proteins and vaccines comprising them |
| US6696249B1 (en) | 1998-05-13 | 2004-02-24 | Institut Pasteur | Method for screening for inhibitors and activators of type III secretion machinery in gram-negative bacteria |
| US6136542A (en) * | 1998-05-13 | 2000-10-24 | Institut Pasteur | Method for screening for inhibitors and activators of type III secretion machinery in gram-negative bacteria |
| WO2001073440A2 (de) * | 2000-03-28 | 2001-10-04 | Schebo Biotech Ag | Nachweis von diarrhogenen e.coli-keimen |
| NZ527322A (en) | 2001-01-04 | 2005-07-29 | Univ Saskatchewan | EHEC cell culture supernatant vaccine |
| CA2339436A1 (fr) | 2001-03-15 | 2002-09-15 | Josee Harel | Production d'anticorps contre les facteurs de virulence associes aux souches d'escherichia coli aeec, et leur utilisation |
| US20060241075A1 (en) * | 2001-05-18 | 2006-10-26 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of desmoglein gene expression using short interfering nucleic acid (siNA) |
| WO2004050119A1 (en) * | 2002-11-29 | 2004-06-17 | Imperial College Innovations Limited | Vaccine against enteropathogenic and enterohaemorragic escherichia coli |
| WO2005042746A1 (en) | 2003-10-31 | 2005-05-12 | The University Of British Columbia | Bacterial virulence factors and uses thereof |
| GB0411624D0 (en) * | 2004-05-25 | 2004-06-30 | Imp College Innovations Ltd | Products and uses thereof |
| CN101213155B (zh) | 2005-04-28 | 2012-11-21 | 日立金属株式会社 | 半导体陶瓷组合物及其制备方法 |
| WO2008133659A2 (en) | 2006-11-29 | 2008-11-06 | Tufts University | Eschericia coli mutants and methods of use thereof |
| US7923001B2 (en) * | 2007-09-07 | 2011-04-12 | The Regents Of The University Of Michigan | Compositions and methods for diagnosing and treating urinary tract infections |
| WO2010115278A1 (en) | 2009-04-06 | 2010-10-14 | University Of Saskatchewan | Methods and compositions for treating and preventing shiga toxin-producing escherichia coli infection |
| US20110229512A1 (en) * | 2010-03-19 | 2011-09-22 | The Regents Of The University Of Michigan | Compositions and methods for diagnosing and treating urinary tract infections |
| DK2550366T3 (en) * | 2010-03-23 | 2014-12-15 | Imba Inst Für Molekulare Biotechnologie Gmbh | Methods for identifying inhibitors of the type III secretion system |
| GB201621686D0 (en) * | 2016-12-20 | 2017-02-01 | Glaxosmithkline Biologicals Sa | Novel methods for inducing an immune response |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US15999A (en) | 1856-10-28 | Improved projectile for ordnance | ||
| CA2078716A1 (en) * | 1992-09-21 | 1994-03-22 | Joyce De Azavedo | Attaching and effacing protein of enterohemorrhagic e. coli |
| US6090623A (en) * | 1993-08-11 | 2000-07-18 | Merck & Co., Inc. | Recombinant human calcium channel β4 subunits |
| ES2389625T3 (es) | 1996-04-23 | 2012-10-29 | The University Of British Columbia | Vacuna que comprende la proteína EspA asociada a Escherichia coli patógena |
-
1997
- 1997-04-23 ES ES97917185T patent/ES2389625T3/es not_active Expired - Lifetime
- 1997-04-23 US US09/171,517 patent/US6355254B1/en not_active Expired - Lifetime
- 1997-04-23 WO PCT/CA1997/000265 patent/WO1997040063A2/en not_active Ceased
- 1997-04-23 BR BR9710433-7A patent/BR9710433A/pt not_active Application Discontinuation
- 1997-04-23 JP JP09537532A patent/JP2000511771A/ja not_active Ceased
- 1997-04-23 EP EP97917185A patent/EP0904288B1/en not_active Expired - Lifetime
- 1997-04-23 AU AU25628/97A patent/AU2562897A/en not_active Abandoned
- 1997-04-23 KR KR1019980708638A patent/KR20000010667A/ko not_active Withdrawn
- 1997-04-23 CA CA2252372A patent/CA2252372C/en not_active Expired - Fee Related
- 1997-04-23 DK DK97917185.7T patent/DK0904288T3/da active
-
2001
- 2001-09-28 US US09/967,347 patent/US7078193B2/en not_active Expired - Fee Related
-
2006
- 2006-04-25 US US11/411,382 patent/US7214499B2/en not_active Expired - Fee Related
-
2007
- 2007-03-29 US US11/693,665 patent/US8021861B2/en not_active Expired - Fee Related
-
2008
- 2008-09-11 JP JP2008233530A patent/JP5058106B2/ja not_active Expired - Fee Related
-
2010
- 2010-03-01 JP JP2010043983A patent/JP2010132698A/ja active Pending